OrbiMed’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.9M Buy
1,199,300
+547,272
+84% +$11.4M 0.62% 40
2025
Q1
$11.3M Hold
652,028
0.27% 57
2024
Q4
$17.7M Buy
652,028
+268,323
+70% +$7.28M 0.36% 57
2024
Q3
$16.8M Buy
383,705
+258,705
+207% +$11.4M 0.31% 70
2024
Q2
$4.91M Buy
+125,000
New +$4.91M 0.1% 87